Biopharmaceutical companies continue to hunt for new immunology drugs that bring patients the same benefit as injectable antibody medicines, but in the form of more convenient daily pills. Coultreon ...

Update: "Low quality, obvious AI-created slop is going to be a growing problem in every creative outlet," Facepunch founder Garry Newman said in response on RPS' reachout about S&box being plagued by ...

Among the cadre of birds that dart along the tree line bordering the Great Western Trail near Lombard is a green-plumed flock that looks completely out of place. That’s because they are. For decades, ...

The pill is the most common way Australian women avoid getting pregnant. Almost 30% of Australian women who use contraception take the pill. Now, several state and territory governments are giving ...

Corrections: This story was updated to clarify the findings of clinical trials and out-of-pocket cost information. As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles ...

WASHINGTON, April 6 (Reuters) - Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo Nordisk (NOVOb.CO), opens new tab ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. INDIANAPOLIS, INDIANA - MARCH 17: A flag flies above the headquarters campus of Eli Lilly ...

Bottle of Foundayo, a GLP-1 pill from Eli Lilly approved by the FDA to treat obesity Bottle of Foundayo, a GLP-1 pill from Eli Lilly approved by the FDA to treat obesityEli Lilly & Company Senior ...

Eli Lilly’s once-daily pill for weight loss got approval from U.S. drug regulators Wednesday. The all-clear sets up a battle with rival Novo Nordisk, which has been selling a pill version of its ...

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...